Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.93
-0.3500-4.81%
Post-market: 6.930.00000.00%19:34 EDT
Volume:677.11K
Turnover:4.79M
Market Cap:376.15M
PE:-2.82
High:7.43
Open:7.33
Low:6.91
Close:7.28
Loading ...

Emergent BioSolutions Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
15 Jul

Aptevo Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Dirk Huebner, SVP and CMO

Reuters
·
10 Jul

Emergent BioSolutions: Strategic Positioning and Achievements Drive Buy Rating

TIPRANKS
·
09 Jul

Emergent BioSolutions Shares Rise Over 6% After HHS Contract Modification

Dow Jones
·
09 Jul

Emergent BioSolutions secures $51.9M contract modification

TIPRANKS
·
09 Jul

Emergent BioSolutions Secures $51.9 Million Contract for Smallpox Treatment with U.S. Government

Reuters
·
09 Jul

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for Cnj-016® [Vaccinia Immune Globulin Intravenous (Human)] (Vigiv) as Part of U.S. Biodefense Preparedness Efforts

THOMSON REUTERS
·
09 Jul

Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way?

Simply Wall St.
·
05 Jul

Emergent BioSolutions expands NARCANDirect online distribution network

TIPRANKS
·
03 Jul

Emergent BioSolutions Expands Narcandirect® to Offer Kloxxado® (Naloxone Hcl) Nasal Spray 8 Mg and Convenience Kits Amid Changes in Overdose Death Rate

THOMSON REUTERS
·
03 Jul

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

GlobeNewswire
·
03 Jul

Emergent BioSolutions Secures $62.4M ASPR Contract Modification

TIPRANKS
·
25 Jun

Aptevo Therapeutics Appoints Baker Tilly as New Auditor Following Moss Adams Merger

Reuters
·
24 Jun

Refile-Emergent BioSolutions Shares up 3.1% After US Awards Additional $62.4 Million for Botulism Treatment Stockpile Contract (Adds Dropped Word)

THOMSON REUTERS
·
23 Jun

Emergent BioSolutions Shares up 3.1% US Awards Additional $62.4 Million for Botulism Treatment Stockpile Contract

THOMSON REUTERS
·
23 Jun

BUZZ-Emergent rises as US awards additional $62.4 million for botulism treatment stockpile

Reuters
·
23 Jun

Emergent BioSolutions Secures $62.4 Million Contract to Supply Botulism Antitoxin to U.S

Reuters
·
23 Jun

Emergent BioSolutions Secures $62.4 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

THOMSON REUTERS
·
23 Jun

Aptevo Therapeutics Expands CD3 Portfolio with New APVO455 Candidate Targeting Solid Tumors

Reuters
·
20 Jun

Emergent BioSolutions Inc. Joins Russell 3000® Index

Reuters
·
20 Jun